Relievion device- Treatment stimulation
Sponsors
Neurolief Ltd.
Conditions
Migraine
Unknown Phase
A Randomized, Double-blind Clinical Investigation to Evaluate the Use of the Relievion™ Device in Treating Migraine.
TerminatedNCT03185559
Start: 2017-07-23End: 2018-01-09Updated: 2018-03-29
Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine
CompletedNCT03398668
Start: 2018-02-22End: 2018-12-30Updated: 2019-03-13